EPRXF   $5.1  -13.12% Market Closed

Eupraxia Pharmaceuticals Inc
Total Cash 33.21M
totalCashPerShare 1.218
EBITDA -29.98M
Total Debt 15.41M
quickRatio 1.728
currentRatio 1.752
Total Revenue
debtToEquity 102.344
Revenue/Share
ROA -0.57172
ROE -2.05968
grossProfits
freeCashflow -15.29M
operatingCashflow -25.09M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 66.65M
forwardPE
floatShares 22.88M
sharesOutstanding 35.62M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.08%
heldPercentInstitutions 0.12%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 0.625
Price To Book help_outline 4.86
earningsQuarterlyGrowth
netIncomeToCommon -34.41M
trailingEps -1.13%
forwardEps
enterpriseToEbitda -2.22
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 3
lastUpdated April 16, 2024, 9:52 p.m.